Molecular Testing

  • April 13, 2022  

    Cancer Commons Adapts to Remain True to Our Mission

    With: Shelley Frisbie

    People facing advanced cancer come to Cancer Commons to ensure they have all the information they need to make their best-possible cancer care decisions. Here, Curious Dr. George asks our CFO & COO Shelley Frisbie about recent updates to our organization. Curious Dr. George: You have been the CFO of Cancer Commons for some time and recently added the COO title and duties to… Read more »

  • March 22, 2022  

    Immunotherapy Approvals Signal a Need for Molecular Testing in Endometrial Cancer Bookmark

    George Lundberg, MD

    Molecular testing often guides choices of immunotherapy, as illustrated in this OncLive story about endometrial cancer.

    .

  • March 22, 2022  

    Biomarker Testing for Cancer Treatment Bookmark

    George Lundberg, MD

    Each person with cancer has unique biomarkers that may determine how well specific treatments might work for them. Learn more from this website all about biomarkers, prepared by the National Cancer Institute.

    .

  • March 8, 2022  

    Using Protein Analysis to Understand Esophageal Cancer Bookmark

    George Lundberg, MD

    In order to advance knowledge that leads to better treatments for esophageal diseases, biomarkers of genomic, proteomic, and metabolomic types may be required. One company, Stella Diagnostics, received a Biotech Breakthrough Award in 2021 for its proteomics work in this often-neglected cancer.

    .

    .

  • March 3, 2022  

    More Information from Less Tissue: Strata Oncology Excels

    With: Scott A. Tomlins, MD, PhDLaura E. Lamb, PhD

    For a growing number of advanced cancer patients, molecular testing of tumor tissue is an essential step in identifying their best options for treatment. Strata Oncology is one company offering this kind of test. Here, our Curious Dr. George asks two of its leaders what sets Strata apart. Curious Dr. George: No loop is stronger than its weakest link. In the “brain-to-brain” concept of… Read more »

  • June 12, 2021  

    Improving Access to Genetic Testing and Counseling Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Learn about eReach, a study investigating whether telehealth can provide improved access to genetic testing for people at risk for cancer.

    .

  • June 12, 2021  

    Decoding the Differences between At-Home and Medical Genetic Testing Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Learn about how the cost, access, accuracy, privacy and other aspects of at-home genetic testing compare to medical genetic testing with a specialist. 

    .

  • June 12, 2021  

    Tumor Biology Matters Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Results from the Know Your Tumor program shows overall survival benefit for patients with an actionable alteration and who received a matched therapy, compared to those with an actionable alteration and who did not receive a matched therapy. 

    .

  • June 12, 2021  

    Multi-Site Precision Promise Study Opens Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Learn about Precision Promise, an adaptive multi-site clinical trial spearheaded by the Pancreatic Cancer Action Network.

    .

  • June 12, 2021  

    New Trial to Find Biomarkers to Guide Treatment Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: A new clinical trial is using precision medicine to identify the best individualized standard-of-care options for pancreatic cancer patients.

    .